Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adjuvant, AFAB, alongside, Amtagvi, AON, ASCO, ATM, Bit, BMS, book, broker, buy, buyer, Cabaletta, carryforward, CDI, celiac, chairperson, circumstance, Clawback, CODM, cold, correlated, criterion, decade, deconvolution, Deploying, dimension, discerning, dissolve, DLT, downregulated, extramedullary, Forest, Gaza, Gracell, hardware, Herald, heterogeneity, hot, Ideal, immunosuppressive, inadvisable, induction, infiltrate, Inline, intercellular, intestate, intracellular, intrusion, Iridium, Jeff, Karverna, killer, Linkbase, Lisata, London, lympho, Lymphoblastic, MHC, MOA, modest, MPA, mRNA, multiplex, murine, neoantigen, network, NIST, penetrate, penetration, perpetrated, polyclonal, posture, predictor, pro, prompt, Quell, rata, reconvene, SAB, Sangamo, shell, shift, Simplification, stayed, steroid, Stover, Sucampo, tabletop, Taxonomy, TCE, TEAE, threat, Timothy, transient, Treg, triage, unintentional, unremediated, unwarranted, Wake, Warrant, warranted, washout, Weber, Wednesday, Wittenberg, XBRL
Removed:
Academy, annum, Archigen, Assistant, attendance, Bank, BCF, Biochemistry, borrowed, Brunswick, CEO, Chase, combine, compelled, contractually, Cornell, correction, Corvidia, distinguishing, Downstate, enasidenib, essence, evidencing, evident, extinguishment, forgiven, Fujifilm, Gastroenterology, gastrointestinal, Greene, Greensboro, Harvard, hedging, hybrid, IMiD, Immodulon, immunochemistry, infection, invested, Janssen, JPMorgan, Kirin, Kyowa, leader, leasing, lenalidomide, load, loan, loaned, mortgage, movement, multiplied, NexGel, NJ, numerator, optional, package, partnering, Paycheck, Piedmont, PPP, precautionary, Professor, PTC, recession, remeasured, remeasurement, remotely, rest, retrospective, Sandoz, SBA, seniority, Soligenix, Sorrento, spent, SQZ, Suite, Summit, suspending, temporarily, thalidomide, thereon, trained, transactional, transporting, troubled, UCLA, undesignated, unrelated, unsecured, week, West, Wood
Filing tables
Filing exhibits
NEXI similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of NexImmune, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge that:
The Annual Report for the year ended December 31, 2023 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 16, 2024 | By: | /s/ Timothy Stover | ||||||
Timothy Stover Vice President, Corporate Controller (Principal Financial Officer and Principal Accounting Officer) |